Jack H. Simon

19.3k total citations · 4 hit papers
114 papers, 11.4k citations indexed

About

Jack H. Simon is a scholar working on Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Neurology. According to data from OpenAlex, Jack H. Simon has authored 114 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Pathology and Forensic Medicine, 32 papers in Radiology, Nuclear Medicine and Imaging and 29 papers in Neurology. Recurrent topics in Jack H. Simon's work include Multiple Sclerosis Research Studies (59 papers), Advanced MRI Techniques and Applications (20 papers) and Peripheral Neuropathies and Disorders (16 papers). Jack H. Simon is often cited by papers focused on Multiple Sclerosis Research Studies (59 papers), Advanced MRI Techniques and Applications (20 papers) and Peripheral Neuropathies and Disorders (16 papers). Jack H. Simon collaborates with scholars based in United States, Canada and United Kingdom. Jack H. Simon's co-authors include Richard A. Rudick, Elizabeth Fisher, Nancy A. Simonian, Anthony Traboulsee, Jeffrey L. Bennett, Kay E. Wellik, Philippe Cabre, Kazuo Fujihara, J. de Sèze and Michael Levy and has published in prestigious journals such as New England Journal of Medicine, American Journal of Psychiatry and Neurology.

In The Last Decade

Jack H. Simon

113 papers receiving 11.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

2015 3.0k citations Dean M. Wingerchuk, Brenda Banwell et al. Neurology profile →
Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis

2000 1.1k citations Jack H. Simon, Nancy A. Simonian et al. profile →
Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial

2009 686 citations Kathleen Hawker, Paul O’Connor et al. Annals of Neurology profile →
Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS

1999 578 citations Richard A. Rudick, Elizabeth Fisher et al. Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jack H. Simon United States	44	8.7k	4.6k	2.9k	1.7k	1.3k	114	11.4k
Angelo Ghezzi Italy	52	8.2k 0.9×	3.6k 0.8×	2.0k 0.7×	1.3k 0.8×	1.1k 0.8×	219	10.1k
Carlo Pozzilli Italy	69	10.0k 1.1×	4.1k 0.9×	2.3k 0.8×	1.8k 1.1×	1.8k 1.4×	385	14.8k
Vittorio Martinelli Italy	57	7.8k 0.9×	3.5k 0.8×	2.1k 0.7×	1.7k 1.0×	1.0k 0.8×	282	10.9k
David MacManus United Kingdom	57	6.4k 0.7×	3.3k 0.7×	1.9k 0.6×	2.2k 1.3×	1.2k 0.9×	146	10.4k
Marco Rovaris Italy	61	8.9k 1.0×	3.6k 0.8×	2.7k 0.9×	2.8k 1.7×	1.1k 0.8×	308	12.1k
Donald W. Paty Canada	32	12.4k 1.4×	4.5k 1.0×	3.5k 1.2×	2.5k 1.5×	1.9k 1.5×	63	16.7k
Mar Tintoré Spain	53	8.4k 1.0×	3.8k 0.8×	2.6k 0.9×	832 0.5×	1.7k 1.3×	239	10.4k
Donald E. Goodkin United States	41	8.7k 1.0×	3.1k 0.7×	2.2k 0.8×	753 0.4×	1.6k 1.2×	80	11.0k
Anthony Traboulsee Canada	47	7.9k 0.9×	4.2k 0.9×	2.3k 0.8×	2.4k 1.4×	1.2k 0.9×	293	11.4k
Giancarlo Comi Italy	63	10.6k 1.2×	3.9k 0.9×	2.8k 1.0×	3.6k 2.2×	1.3k 1.0×	233	14.4k

Countries citing papers authored by Jack H. Simon

Since Specialization

Citations

This map shows the geographic impact of Jack H. Simon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack H. Simon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack H. Simon more than expected).

Fields of papers citing papers by Jack H. Simon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack H. Simon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack H. Simon. The network helps show where Jack H. Simon may publish in the future.

Co-authorship network of co-authors of Jack H. Simon

This figure shows the co-authorship network connecting the top 25 collaborators of Jack H. Simon. A scholar is included among the top collaborators of Jack H. Simon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack H. Simon. Jack H. Simon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spain, Rebecca, Charles Murchison, Fay B. Horak, Jack H. Simon, & Dennis Bourdette. (2016). Lipoic Acid for Neuroprotection in Secondary Progressive Multiple Sclerosis (P1.373). Neurology. 86(16_supplement). 4 indexed citations

Wingerchuk, Dean M., Brenda Banwell, Jeffrey L. Bennett, et al.. (2015). International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 85(2). 177–189. 2985 indexed citations breakdown →

Traboulsee, Anthony, Jack H. Simon, L. Stone, et al.. (2015). Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis. American Journal of Neuroradiology. 37(3). 394–401. 243 indexed citations

Simon, Jack H.. (2014). MRI outcomes in the diagnosis and disease course of multiple sclerosis. Handbook of clinical neurology. 122. 405–425. 21 indexed citations

Kinkel, R. Philip, Jack H. Simon, Paul O’Connor, Robert Hyde, & Amy Pace. (2014). Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndrome. Multiple Sclerosis and Related Disorders. 3(6). 712–719. 6 indexed citations

Wynn, Daniel, Michael D. Kaufman, Xavier Montalbán, et al.. (2010). Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. The Lancet Neurology. 9(4). 381–390. 234 indexed citations

Hawker, Kathleen, Paul O’Connor, Mark S. Freedman, et al.. (2009). Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial. Annals of Neurology. 66(4). 460–471. 686 indexed citations breakdown →

Du, Yiping P., Renxin Chu, Dosik Hwang, et al.. (2007). Fast multislice mapping of the myelin water fraction using multicompartment analysis of T decay at 3T: A preliminary postmortem study. Magnetic Resonance in Medicine. 58(5). 865–870. 155 indexed citations

Rudick, Richard A., Jar-Chi Lee, Jack H. Simon, & Elizabeth Fisher. (2006). Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal study. Annals of Neurology. 60(2). 236–242. 96 indexed citations

10.

Cohen, Jeffrey A., Gary Cutter, Jill S. Fischer, et al.. (2002). Benefit of interferon β-1a on MSFC progression in secondary progressive MS. Neurology. 59(5). 679–687. 307 indexed citations

11.

Simon, Jack H. & W. I. McDonald. (2000). Assessment of optic nerve damage in multiple sclerosis using magnetic resonance imaging. Journal of the Neurological Sciences. 172. S23–S26. 11 indexed citations

12.

Simon, Jack H., et al.. (2000). A Wallerian degeneration pattern in patients at risk for MS. Neurology. 54(5). 1155–1160. 108 indexed citations

13.

Rudick, Richard A., Elizabeth Fisher, Jar-Chi Lee, Jeffrey Duda, & Jack H. Simon. (2000). Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon β-1a. Multiple Sclerosis Journal. 6(6). 365–372. 109 indexed citations

14.

Fazekas, Franz, Frederik Barkhof, Massimo Filippi, et al.. (1999). The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology. 53(3). 448–448. 211 indexed citations

15.

Rojas, Donald C., Peter Teale, Jeanelle Sheeder, Jack H. Simon, & Martin Reite. (1997). Sex-specificity of cerebral asymmetry in heschl's gyrus in paranoid schizophrenia. Schizophrenia Research. 24(1-2). 171–172. 1 indexed citations

16.

Raff, Ulrich, P. Vargas, Gonzalo Rojas, Ann Scherzinger, & Jack H. Simon. (1997). Quantitation of T2 lesion load in multiple sclerosis with magnetic resonance imaging: A pilot study of a probabilistic neural network approach. Academic Radiology. 4(6). 431–437. 5 indexed citations

17.

Waldo, Merilyne C., Ellen Cawthra, Lawrence E. Adler, et al.. (1994). Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings. Schizophrenia Research. 12(2). 93–106. 100 indexed citations

18.

Silliman, Christopher C., D G Tedder, John W. Ogle, et al.. (1993). Unsuspected varicella-zoster virus encephalitis in a child with acquired immunodeficiency syndrome. The Journal of Pediatrics. 123(3). 418–422. 16 indexed citations

19.

Kido, Daniel K., et al.. (1987). Physiologic Changes During High Field Strength MR Imaging. American Journal of Neuroradiology. 8(2). 263–266. 8 indexed citations

20.

Carsin, M., et al.. (1972). [Problems of technic and interpretation of lumbar radiculography].. PubMed. 53(3). 276–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact